<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02719860</url>
  </required_header>
  <id_info>
    <org_study_id>03-0014</org_study_id>
    <nct_id>NCT02719860</nct_id>
  </id_info>
  <brief_title>High Tea Consumption on Smoking Related Oxidative Stress</brief_title>
  <official_title>A Chemoprevention Trial to Study the Effects of High Tea Consumption on Smoking Related Oxidative Stress</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Arizona</source>
  <brief_summary>
    <textblock>
      The overall objective of this study is to determine the effect of high tea consumption on
      biological markers of oxidative stress that mediate lung cancer risk.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-intervention change in urinary 8-hydroxydeoxyguanosine</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-intervention change in urinary 8-F2-isoprostanes</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>Lung Cancer Prevention</condition>
  <arm_group>
    <arm_group_label>Green tea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Black tea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo tea</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Green tea</intervention_name>
    <description>4 cups/day of green tea for 6 months; each cup is prepared by brewing 2 tea bags in 12 oz of water</description>
    <arm_group_label>Green tea</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Black tea</intervention_name>
    <description>4 cups/day of black tea for 6 months; each cup is prepared by brewing 2 tea bags in 12 oz of water</description>
    <arm_group_label>Black tea</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo tea</intervention_name>
    <description>4 cups/day of placebo tea for 6 months; each cup is prepared by brewing 2 tea bags in 12 oz of water</description>
    <arm_group_label>Placebo tea</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  FEV1 &lt; 85% and at least 25 pack-years of current or former smoking history.

          -  No diagnosis of internal cancer within the last 5 years or no chemotherapy or
             radiation for an internal cancer within the last 5 years.

          -  Meets the Southwest Oncology Group (SWOG) performance status criteria of 0-1.

          -  Not be pregnant or intending to get pregnant during the study period (women
             participants).

          -  Willing to drink 4 cups of tea (each cup will be brewed with 2 tea bags and 12 ounces
             of water) for 1-month run-in period and for the 6-month intervention period.

          -  Willing to refrain from consuming other tea or tea products starting one month before
             the placebo run-in period and for the entire study period (a total of 8 months)

          -  Willing to refrain from consuming more than one caffeinated product (coffee, soda..)
             starting one month before the placebo run-in period and for the entire study period (a
             total of 8 months).

          -  Subjects cannot take mega-doses of vitamins during the trial. This is defined as more
             than 400 IU of vitamin E, 200 ug of selenium, or 1 gm of vitamin C per day, or more
             than the tolerable upper limits of any other supplement as defined in the Dietary
             Reference Intake panels developed by the Food and Nutrition Board under the Institute
             of Medicine. Such vitamin therapy must be discontinued at least 2 weeks prior to study
             entry.

        Exclusion Criteria:

          -  Subjects immunosuppressed by virtue of medication or disease.

          -  Serious concurrent illness that could interfere with study regimen.

          -  Subjects with a history of invasive cancer within the past 5 years.

          -  Subjects who are drinking more than 5 cups of non-herbal tea per week.

          -  Subjects who cannot or are unwilling to consume caffeinated beverages.

          -  Subjects unable to perform forced expiratory maneuver during spirometry testing.

          -  More than one acute emphysema exacerbation within the last 6 month -period .

          -  Subjects on oxygen.

          -  Women with positive urinary pregnancy test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2016</study_first_submitted>
  <study_first_submitted_qc>March 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2016</study_first_posted>
  <last_update_submitted>March 24, 2016</last_update_submitted>
  <last_update_submitted_qc>March 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

